- Titan Medical (TMD) has appointed Eric Heinz as the company’s Vice President, Market and Corporate Development
- Heinz will develop and execute strategic business plans to expand and accelerate Titan’s Enos robotic single-access surgical system’s portfolio cadence
- Heinz has more than 20 years of medical device experience across business strategy, corporate development, product development and marketing
- Titan is a medical device company enhancing robotic-assisted surgery using innovative technology through a single access point
- Titan Medical Inc. (TMD) opened trading at C$0.64 per share
Titan Medical (TMD) has appointed Eric Heinz as the company’s Vice President, Market and Corporate Development.
Heinz will develop and execute strategic business plans to expand and accelerate Titan’s Enos robotic single-access surgical system’s portfolio cadence. He will also lead existing partnerships and look to supplement those to maximize Titan’s reach and the utilization of the Enos system.
Cary Vance, the President and CEO of Titan, commented on the appointment.
“We are excited to have Eric join the senior leadership team. Eric brings a proven track record of leading efforts to grow businesses and augment markets in the dynamic surgical robotics industry. It was especially important for us to bring in a leader with extensive experience at leading successful negotiations while driving organic and inorganic growth in the medical technology industry.”
Heinz has more than 20 years of medical device experience across business strategy, corporate development, product development and marketing. He has worked for companies ranging in size from small-cap to multi-nationals. He recently served as Director, Business Development (M&A) for Smith & Nephew.
Prior to joining Smith & Nephew, Heinz consulted with Zimmer Biomet, Medtech Surgical SA and a boutique investment bank. He served as senior marketing manager for the SYMBIS Surgical System MRI-compatible neurosurgical robotics business at IMRIS. He also worked as a product manager over the $500m instruments, accessories and video system portfolio at Intuitive Surgical.
Heinz holds a Master of Engineering Management from Christian Brothers University. He has a Bachelor of Science in Bioengineering from The University of Illinois, Urbana-Champaign. He anticipates graduating with an Executive MBA degree from the Kellogg School of Management at Northwestern University in December 2022.
Titan is a medical device company enhancing robotic-assisted surgery using innovative technology through a single access point.
Titan Medical Inc. (TMD) opened trading at C$0.64 per share.
